FDA issues healthcare professional alert-increased botox injury warning label. New York, NY(NewYorkInjuryNews.com)–The U.S. Food and Drug Administration (FDA) www.fda.gov notified healthcare professionals nationwide on Thursday that Botox manufacturers must strengthen product injury warnings. The FDA is requiring licensed manufacturers of botulinum toxin products (Botox) to place a boxed warning label stating the risk of adverse […]